Abstract
INTRODUCTION
Drugs don't work in patients who don't take them. 1 Treatment failures that are usually assumed to be medication failures may be a result of non-adherence rather than lack of efficacy. 2 Clinical trials were designed to evaluate the efficacy and safety of interventions. Study reviewed the last twenty years of research on patient adherence in clinical trials. The research has shown that up to 30% of clinical trials participants are missing doses and not taking the full dose. 3 Medication adherence, as a major variable, may influence the results and the conclusions of clinical trials. 3, 4 Thus, medication adherence is required to be reported. As early as in 1994, Urquhart J stated that medication adherence evaluation should be part of the clinical trial results. 5 The International Conference on Harmonisation (ICH) guidelines also include recommendations to report adherence: "the measures taken to ensure and document treatment adherence should be described, e.g., drug accountability, diary cards, blood, urine or other body fluid drug level measurements, or medication event monitoring". 6 In order to find out the implementation status of adherence reporting in clinical trial of Traditional Chinese Medicine (TCM), we conducted a cross-sectional sample literature research to assess (a) adherence reporting in randomized clinical trial of TCM for type 2 diabetes mellitus (b) factors affected medication adherence. 
METHODS

Eligible criteria
Literature research
We searched three Chinese electronic literature databases: Chinese Biomedical Literature Database (SinoMed, http://www.sinomed.ac.cn/), China National Knowledge Infrastructure (China journals full-text database, http://www.cnki.net/ ) and Wanfang database (http:// www.wanfangdata.com.cn/) from January 2012 to December 2012. In order to ensure the recall rate, we developed a broad search strategy combined with hand screening. The search terms were as following: 1# To locate articles on disease: "type 2 diabetes" OR "late onset diabetes" OR "maturity onset diabetes" OR "noninsulin dependent diabetes" OR "T2DM" OR "xiaoke" 2# To locate articles on study design:"clinical trial" OR "clinical observation" OR "clinical evaluation" OR "clinical research" OR "clinical study" OR "efficacy evaluation" OR "randomized clinical trial" 3# 1#AND2# The terms in Chinese were used as free-text words and keywords.
Literature screening and information extraction
Two authors screened literatures according to the eligible criteria and extracted information dependently. Divergence in the process of literature screening and information extraction was resolved by discussion. The extracted data include: author, type of interventions, name of research organizations, medication frequency, medication adherence, medication adherence method, etc.
RESULTS
Electronic literature search retrieved 6299 titles. After screening according to the eligible criteria, 124 trials were included finally. Figure 1 was the literature screening flow diagram. The information relevant with medical ethics of included trials was summarized in Table 1 . None of the trials reported the medication adherence. Most studies (68.5%) testified the efficacy of decoction of prescriptions. Medications in more than 50% studies were taken twice. The course of treatment in 89 studies (71.7%) was 4 to 12 weeks. 56 studies were carried out in Medical University and affiliated hospital. 21 studies were funded by government.
Due to no trials reported medication adherence rate, the factors impacting medication adherence couldn't be analyzed.
DISCUSSION
Transparent adherence reporting is crucial to understanding the explanations of clinical results and the effectiveness and safety of interventions applied to new clinical population. 3 However, the findings in our study were somewhat disheartening in respect to reporting medication adherence in TCM clinical trials. Several reasons might lead to the problems: (a) being unaware of the significance of medication adherence. Participants' medication adherence in clinical trials affect the accuracy of the study results as well as the lives of future patients who will be taking the study medication once it has been approved. 7 Adherence could also provide information concerning participants' acceptability of assigned treatments. Investigators need to be concerned about the medication adherence. However, investigators have not recognized the necessity and importance of medication adherence. (b) Difficulty in adherence assessment. Though many assessment methods has been explored and employed in clinical trials, all ex- isting methods have certain disadvantages.
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The sensitivity of medication adherence scale or questionnaire varied, and the results of some adherence assessment tools tend to be affected by recalling bias and patient preference. 10, 11 (c) No medication adherence reporting standard. The medication adherence could be reported as a quantitative measure (i.e., as a proportion of prescribed treatment) or as a qualitative measure, i.e., adherent versus non-adherent, high versus medium versus low adherence). (d) Dereliction of medical journals. Editors need to be aware the medication adherence may influence the result and conclusion of clinical trials and require that the study could not be accepted until the medication adherence reported. To change the situation, attentions need to be paid: (a) To strengthen medical adherence education. Investigators, medical college students, authors medical journal editors are all required the training of medication adherence. (b) Establishing reliable medication adherence evaluation method. The ideal assessment method should be easy to application, objective and accurate, and inexpensive. (c) Establishing medication adherence reporting standard. Establishing medication adherence reporting standard would be beneficial to authors. This is a cross-section sample literature study. Only RCTs of TCM for treatment of type 2 diabetes mellitus published in Chinese journal were included. Clinical trials of TCM published in English journals might yield different results.
In conclusion, lack of medication adherence reporting is serious issues in clinical trials in TCM. Establishing standards for assessment of adherence and its reporting may be important steps for improving the quality of clinical studies in the field of TCM research. 
